Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Serina Therapeutics (SER) Return on Invested Capital (2019)

Serina Therapeutics (SER) has disclosed Return on Invested Capital for 1 consecutive years, with 3.2% as the latest value for Q4 2019.

  • Quarterly Return on Invested Capital changed N/A to 3.2% in Q4 2019 from the year-ago period, while the trailing twelve-month figure was 3.2% through Dec 2019, changed N/A year-over-year, with the annual reading at 101.88% for FY2025, N/A changed from the prior year.
  • Return on Invested Capital hit 3.2% in Q4 2019 for Serina Therapeutics.
  • In the past five years, Return on Invested Capital ranged from a high of 3.2% in Q4 2019 to a low of 3.2% in Q4 2019.